By Alicia Mundy As Food and Drug Administration officials examine internal controls in the wake of insider-trading charges filed against a longtime employee, a primary challenge will be how to limit access to valuable information without clogging up the approval process. The computer database that chemist Cheng Yi Liang is accused of exploiting to make […]